The global artificial intelligence (AI) in biopharmaceutical market size is calculated at USD 1.51 billion in 2024, grew to USD 1.99 billion in 2025, and is predicted to hit around USD 24.73 billion by 2034, expanding at a CAGR of 32.25% between 2024 and 2034. The North America artificial intelligence (AI) in biopharmaceutical market size accounted for USD 680 million in 2024 and is anticipated to grow at the fastest CAGR of 32.39% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Artificial Intelligence (AI) in Biopharmaceutical Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Artificial Intelligence (AI) in Biopharmaceutical Market, by Application, 2024-2034
8.1.1. Drug Discovery
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Precision Medicine
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Medical Imaging & Diagnostics
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Research
8.1.4.1. Market Revenue and Forecast (2021-2034)
9.1. Artificial Intelligence (AI) in Biopharmaceutical Market, by Technology, 2024-2034
9.1.1. Machine Learning
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Natural Language Processing
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Deep Learning
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2021-2034)
10.1. Artificial Intelligence (AI) in Biopharmaceutical Market, by Offering, 2024-2034
10.1.1. Hardware
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Software
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Services
10.1.3.1. Market Revenue and Forecast (2021-2034)
11.1. Artificial Intelligence (AI) in Biopharmaceutical Market, by Deployment, 2024-2034
11.1.1. Cloud
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. On-Premises
11.1.2.1. Market Revenue and Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Forecast, by Application (2021-2034)
12.1.2. Market Revenue and Forecast, by Technology (2021-2034)
12.1.3. Market Revenue and Forecast, by Offering (2021-2034)
12.1.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Application (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Offering (2021-2034)
12.1.5.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Application (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Technology (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Offering (2021-2034)
12.1.6.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Application (2021-2034)
12.2.2. Market Revenue and Forecast, by Technology (2021-2034)
12.2.3. Market Revenue and Forecast, by Offering (2021-2034)
12.2.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Application (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Offering (2021-2034)
12.2.5.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Application (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Technology (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Offering (2021-2034)
12.2.6.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Application (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Technology (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Offering (2021-2034)
12.2.7.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Application (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Technology (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Offering (2021-2034)
12.2.8.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Application (2021-2034)
12.3.2. Market Revenue and Forecast, by Technology (2021-2034)
12.3.3. Market Revenue and Forecast, by Offering (2021-2034)
12.3.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Application (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Offering (2021-2034)
12.3.5.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Application (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Technology (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Offering (2021-2034)
12.3.6.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Application (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Technology (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Offering (2021-2034)
12.3.7.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Application (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Technology (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Offering (2021-2034)
12.3.8.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Application (2021-2034)
12.4.2. Market Revenue and Forecast, by Technology (2021-2034)
12.4.3. Market Revenue and Forecast, by Offering (2021-2034)
12.4.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Application (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Offering (2021-2034)
12.4.5.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Application (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Technology (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Offering (2021-2034)
12.4.6.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Application (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Technology (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Offering (2021-2034)
12.4.7.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Application (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Technology (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Offering (2021-2034)
12.4.8.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Application (2021-2034)
12.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.5.3. Market Revenue and Forecast, by Offering (2021-2034)
12.5.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Application (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Technology (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Offering (2021-2034)
12.5.5.4. Market Revenue and Forecast, by Deployment (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Application (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Technology (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Offering (2021-2034)
12.5.6.4. Market Revenue and Forecast, by Deployment (2021-2034)
13.1. IBM Watson Health
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Google Health
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. NVIDIA Corporation
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Microsoft Healthcare
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. DeepMind
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Atomwise
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Insilico Medicine
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. PathAI
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Tempus
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. GNS Healthcare
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample